More Information Coming Soon
Future Home of Belgravia Capital International

About Belgravia Capital

Belgravia Capital International Inc. is focused on its three core business divisions: Incubator, Investments and Royalty Management Services. The Incubator division will provide services and capital to support the development of early-stage companies in the Biotech/Healthcare, Technology, Resources and Legal Medical Cannaceutical sector. Belgravia Holdings, the Investments division, invests in various private and public companies with a focus on an opportunistic basis. Belgravia Royalty Management Services has developed a targeted royalty and fee income model. Further, the developing cash and investment asset base can also support international expansion on a selective basis.

Latest News

April 18, 2018
Belgravia Appoints Dr. Sam Hanna Chief Medical Officer Of Cannabis Dermatology Division

March 12, 2018
BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee

February 28, 2018
BELGRAVIA CAPITAL signs Binding Letter of Intent with R&D Pharma Corp., a developer of a vertically integrated medicinal cannabis business in Jamaica, to invest Canadian $1,000,000.

January 25, 2018
BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry

January 12, 2018
BELGRAVIA CAPITAL INTERNATIONAL announces closing of private placement

January 10, 2018
BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments

January 4, 2018
BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.

January 3, 2018
BELGRAVIA CAPITAL INTERNATIONAL moves to build fully-owned subsidiary in Blockchain and Cannabis Industry

December 5, 2017
BELGRAVIA CAPITAL Corporate Update

November 22, 2017
IC Potash announces trading date on Canadian Securities Exchange under new name ‘Belgravia Capital International’

November 20, 2017
IC Potash provides update on listing on Canadian Stock Exchange

November 7, 2017
IC Potash announces pending move of trading venue to Canadian Securities Exchange

November 6, 2017
IC Potash announces expanded ICP Organics development strategy to include value-added cannabis industry products and services, including permissioned and private blockchain technologies

Annual Meeting 2018

View Annual and Special Meeting Materials

Financials

2017 Annual Audited Financial Statements

2017 Annual Management’s Discussion and Analysis

Contact

Telephone & Email

Jason Batista: + 1 416 579 6850
Jbatista@blgv.ca

Address

Belgravia Capital International
Administration Department
#3-3185 Via Centrale
Kelowna, BC V1V 2A7